170 related articles for article (PubMed ID: 9987673)
1. Thrombospondin-1, PECAM-1, and regulation of angiogenesis.
Sheibani N; Frazier WA
Histol Histopathol; 1999 Jan; 14(1):285-94. PubMed ID: 9987673
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype.
Sheibani N; Frazier WA
Mol Biol Cell; 1998 Apr; 9(4):701-13. PubMed ID: 9529372
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis.
Sheibani N; Newman PJ; Frazier WA
Mol Biol Cell; 1997 Jul; 8(7):1329-41. PubMed ID: 9243511
[TBL] [Abstract][Full Text] [Related]
4. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.
Tolsma SS; Volpert OV; Good DJ; Frazier WA; Polverini PJ; Bouck N
J Cell Biol; 1993 Jul; 122(2):497-511. PubMed ID: 7686555
[TBL] [Abstract][Full Text] [Related]
5. Polyoma virus middle-T-transformed PECAM-1 deficient mouse brain endothelial cells proliferate rapidly in culture and form hemangiomas in mice.
Rothermel TA; Engelhardt B; Sheibani N
J Cell Physiol; 2005 Jan; 202(1):230-9. PubMed ID: 15389523
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 deficient mice exhibit an altered expression pattern of alternatively spliced PECAM-1 isoforms in retinal vasculature and endothelial cells.
Wang Y; Su X; Wu Z; Sheibani N
J Cell Physiol; 2005 Jul; 204(1):352-61. PubMed ID: 15672414
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.
Ridnour LA; Isenberg JS; Espey MG; Thomas DD; Roberts DD; Wink DA
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13147-52. PubMed ID: 16141331
[TBL] [Abstract][Full Text] [Related]
8. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis.
DiPietro LA; Nebgen DR; Polverini PJ
J Vasc Res; 1994; 31(3):178-85. PubMed ID: 7511943
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells.
Castle VP; Dixit VM; Polverini PJ
Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis.
Tzeng HT; Tsai CH; Yen YT; Cheng HC; Chen YC; Pu SW; Wang YS; Shan YS; Tseng YL; Su WC; Lai WW; Wu LW; Wang YC
Clin Cancer Res; 2017 May; 23(9):2335-2345. PubMed ID: 28151721
[No Abstract] [Full Text] [Related]
13. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.
Veliceasa D; Ivanovic M; Hoepfner FT; Thumbikat P; Volpert OV; Smith ND
FEBS J; 2007 Dec; 274(24):6365-77. PubMed ID: 18021253
[TBL] [Abstract][Full Text] [Related]
14. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.
Isenberg JS; Calzada MJ; Zhou L; Guo N; Lawler J; Wang XQ; Frazier WA; Roberts DD
Matrix Biol; 2005 Apr; 24(2):110-23. PubMed ID: 15890262
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration.
Wang S; Wu Z; Sorenson CM; Lawler J; Sheibani N
Dev Dyn; 2003 Dec; 228(4):630-42. PubMed ID: 14648840
[TBL] [Abstract][Full Text] [Related]
16. Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1.
Chandrasekaran L; He CZ; Al-Barazi H; Krutzsch HC; Iruela-Arispe ML; Roberts DD
Mol Biol Cell; 2000 Sep; 11(9):2885-900. PubMed ID: 10982388
[TBL] [Abstract][Full Text] [Related]
17. CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptotaxis on immobilized thrombospondin-1.
Magnetto S; Bruno-Bossio G; Voland C; Lecerf J; Lawler J; Delmas P; Silverstein R; Clezardin P
Cell Biochem Funct; 1998 Sep; 16(3):211-21. PubMed ID: 9747513
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 modulates the angiogenic phenotype of human cerebral arteriovenous malformation endothelial cells.
Stapleton CJ; Armstrong DL; Zidovetzki R; Liu CY; Giannotta SL; Hofman FM
Neurosurgery; 2011 May; 68(5):1342-53; discussion 1353. PubMed ID: 21307796
[TBL] [Abstract][Full Text] [Related]
19. Enhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells.
Wang Y; Wang S; Sheibani N
Microvasc Res; 2006 May; 71(3):143-51. PubMed ID: 16624339
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.
Huang H; Campbell SC; Bedford DF; Nelius T; Veliceasa D; Shroff EH; Henkin J; Schneider A; Bouck N; Volpert OV
Mol Cancer Res; 2004 Oct; 2(10):541-50. PubMed ID: 15498928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
